StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$105.88+0.28 (+0.27%)

Close on Nov 17, 2026Market cap $4.73BP/E –Yield –

Grail cash

Cash and short-term investments held at the end of each period.

Grail's cash was $859.54M at Jun 30, 2026. For fiscal 2025 it was $901.94M, up 18.5% from the year before. The highest annual figure on record is $901.94M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$901.94M+18.5%
FY2024Dec 31, 2024$761.38M+682.6%
FY2023Dec 31, 2023$97.29M-60.5%
FY2022Jan 1, 2023$246.13M+8.9%
FY2021Jan 3, 2022$225.99M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$859.54M+43.1%
Q1 FY2026Mar 31, 2026$820.31M+22.0%
Q4 FY2025Dec 31, 2025$901.94M+18.5%
Q3 FY2025Sep 30, 2025$538.17M-36.9%
Q2 FY2025Jun 30, 2025$600.62M-37.4%
Q1 FY2025Mar 31, 2025$672.60M+236.8%
Q4 FY2024Dec 31, 2024$761.38M+682.6%
Q3 FY2024Sep 30, 2024$853.55M+493.4%
Q2 FY2024Jun 30, 2024$958.85M+315.8%
Q1 FY2024Mar 31, 2024$199.72M-18.9%
Q4 FY2023Dec 31, 2023$97.29M-57.0%
Q3 FY2023Oct 1, 2023$143.84M–
Q2 FY2023Jun 30, 2023$230.62M–
Q4 FY2022Jan 1, 2023$246.13M–
Q4 FY2021Jan 3, 2022$225.99M–

More Grail figures

See a number that looks wrong?